Milestones
  • gland slide
  • gland slide

1978

PVN Raju founds Gland Pharma to manufacture and market Heparin for the domestic market and provides contract manufacturing services for other pharmaceutical companies

1996

Becomes the first company to set up a PFS facility in India, in collaboration with Vetter Pharma, Germany

1998

Flagship manufacturing facility at Dundigal becomes operational

2000

  • Signs its first Contract Manufacturing agreement for regulated markets
  • First R&D facility set up at Dundigal, Hyderabad

2001

Launches Enoxaparin, the world’s first generic, in India

2002

Introduces Enoxaparin in Brazil and other semi-regulated markets

2003

Dundigal facility receives USFDA acceptance

2007

Enters the US market with Ketorolac PFS

2010

Introduces Heparin, its flagship product, in the US market

2011

  • Forays into Australia with Azithromycin Inj.
  • Rocuronium, the first product approval in New Zealand

2012

  • Dundigal facility receives UK MHRA and EMEA approvals
  • Second R&D facility set up at Bollarum, Hyderabad

2013

  • Enters Europe with Tirofiban
  • Oncology facility at Visakhapatnam receives USFDA acceptance

2014

  • Dedicated facility for Penems goes on stream at Pashamylaram, Hyderabad
  • Ophthalmic line and automated Bag line added at Dundigal facility
  • Enters Canada with Amiodarone PFS